Parametric Portfolio Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $228M | Buy |
|
|||||
|
2021
Q4 | $190M | Buy |
|
|||||
|
2021
Q3 | $174M | Buy |
|
|||||
|
2021
Q2 | $142M | Buy |
|
|||||
|
2021
Q1 | $114M | Sell |
|
|||||
|
2020
Q4 | $125M | Sell |
|
|||||
|
2020
Q3 | $145M | Buy |
|
|||||
|
2020
Q2 | $151M | Buy |
|
|||||
|
2020
Q1 | $108M | Buy |
|
|||||
|
2019
Q4 | $63.9M | Sell |
|
|||||
|
2019
Q3 | $47.5M | Sell |
|
|||||
|
2019
Q2 | $58.7M | Sell |
|
|||||
|
2019
Q1 | $102M | Buy |
|
|||||
|
2018
Q4 | $88.8M | Buy |
|
|||||
|
2018
Q3 | $86M | Buy |
|
|||||
|
2018
Q2 | $58.1M | Sell |
|
|||||
|
2018
Q1 | $61.5M | Sell |
|
|||||
|
2017
Q4 | $70.2M | Buy |
|
|||||
|
2017
Q3 | $74.6M | Buy |
|
|||||
|
2017
Q2 | $72.2M | Buy |
|
|||||
|
2017
Q1 | $49.7M | Sell |
|
|||||
|
2016
Q4 | $49.8M | Sell |
|
|||||
|
2016
Q3 | $79.1M | Buy |
|
|||||
|
2016
Q2 | $52.7M | Buy |
|
|||||
|
2016
Q1 | $37.4M | Buy |
|
|||||
|
2015
Q4 | $51M | Buy |
|
|||||
|
2015
Q3 | $37M | Buy |
|
|||||
|
2015
Q2 | $38.6M | Sell |
|
|||||
|
2015
Q1 | $36.5M | Buy |
|
|||||
|
2014
Q4 | $31.4M | Sell |
|
|||||
|
2014
Q3 | $27.6M | Buy |
|
|||||
|
2014
Q2 | $20.9M | Buy |
|
|||||
|
2014
Q1 | $20.6M | Buy |
|
|||||
|
2013
Q4 | $16.2M | Buy |
|
|||||
|
2013
Q3 | $17.9M | Buy |
|
|||||
|
2013
Q2 | $11.7M | Buy |
|